|
|
|
Insider
Information: |
Best Lawrence C |
Relationship: |
Director |
City: |
Braintree |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
385,780 |
|
Indirect Shares
|
8,680 |
|
|
Direct
Value |
$27,085,556 |
|
|
Indirect Value
|
$654,125 |
|
|
Total
Shares |
394,460 |
|
|
Total
Value |
$27,739,681 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP |
2007-07-06 |
309,389 |
2007-07-06 |
8,680 |
Premium* |
|
Haemonetics Corp |
HAE |
Director |
2014-06-12 |
10,001 |
2006-06-16 |
0 |
Premium* |
|
Biogen Idec Inc |
BIIB |
Director |
2008-06-19 |
5,600 |
2007-05-25 |
0 |
Premium* |
|
Myriad Genetics Inc |
MYGN |
Director |
2019-12-05 |
60,790 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MYGN |
Myriad Genetics Inc |
Director |
|
2011-06-07 |
4 |
D |
$24.58 |
$2,458,150 |
D/D |
(100,000) |
0 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2010-02-18 |
4 |
S |
$53.42 |
$2,670,850 |
D/D |
(50,000) |
1,008 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2007-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2010-07-29 |
4 |
A |
$54.48 |
$64,995 |
D/D |
1,193 |
2,201 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2011-02-04 |
4 |
S |
$61.06 |
$934,548 |
D/D |
(15,305) |
2,201 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2011-02-07 |
4 |
S |
$61.65 |
$1,032,678 |
D/D |
(16,695) |
2,201 |
0 |
- |
|
BSX |
Boston Scientific Corp |
officerTitle |
|
2003-08-05 |
4 |
A |
$64.10 |
$176,467 |
I/I |
2,753 |
2,753 |
|
- |
|
HAE |
Haemonetics Corp |
Director |
|
2011-07-21 |
4 |
A |
$0.01 |
$9 |
D/D |
944 |
3,145 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2007-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
2,300 |
3,550 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2012-07-27 |
4 |
A |
$0.01 |
$10 |
D/D |
1,031 |
4,176 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Director |
|
2008-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,050 |
5,600 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2011-02-07 |
4 |
OE |
$20.47 |
$521,153 |
D/D |
16,695 |
6,896 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2013-05-03 |
4 |
S |
$38.32 |
$459,830 |
D/D |
(12,000) |
8,352 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2014-12-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2013-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,649 |
10,001 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-06-12 |
4 |
S |
$33.91 |
$311,440 |
D/D |
(9,184) |
10,001 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Sr. Vice President and CFO |
|
2003-10-03 |
4 |
AS |
$65.90 |
$680,382 |
D/D |
(10,300) |
12,466 |
|
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-06-12 |
4 |
OE |
$24.96 |
$229,233 |
D/D |
9,184 |
15,001 |
0 |
- |
|
MYGN |
Myriad Genetics Inc |
Director |
|
2015-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
17,500 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2011-02-04 |
4 |
OE |
$20.47 |
$313,217 |
D/D |
15,305 |
17,506 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2013-05-03 |
4 |
OE |
$26.38 |
$316,560 |
D/D |
12,000 |
20,352 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Sr. Vice President and CFO |
|
2003-10-03 |
4 |
AS |
$65.80 |
$2,038,720 |
D/D |
(30,800) |
22,766 |
|
- |
|
BSX |
Boston Scientific Corp |
SVP and CFO |
|
2004-01-26 |
4 |
AS |
$40.00 |
$1,000,000 |
D/D |
(25,000) |
30,438 |
|
- |
|
BSX |
Boston Scientific Corp |
SVP and CFO |
|
2004-01-27 |
4 |
AS |
$40.00 |
$13,000,010 |
D/D |
(325,000) |
30,438 |
|
- |
|
BSX |
Boston Scientific Corp |
SVP and CFO |
|
2004-01-28 |
4 |
AS |
$40.00 |
$160,000 |
D/D |
(4,000) |
30,438 |
|
- |
|
108 Records found
|
|
Page 1 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|